In addition to appetite suppression and increased satiety, semaglutide GLP-1 offers other benefits
Laura Dedmon MBBS, MSci Senior Medical Science Editor and Educator, HMX, Harvard Medical School Josephine Li MD Assistant Professor of Medicine, Harvard Medical School Clinical Director, MGH Diabetes Center Physician, MGB Division of Endocrinology Request Information Interested in learning more about this program
Orforglipron may not surpass the efficacy benchmarks set by injectables like tirzepatide or semaglutide, but its superior convenience over existing oral options might make effective GLP-1 therapy accessible to more patients
GLP-1 blocks glucagon (a hormone that works to raise blood sugar) and signals to the pancreas to release insulin
Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR)
Auvelity vs